Latest News
I love writing guest articles and collaborating
See appearances for Asa's events and podcasts
Sep 15, 2025
Interview
Claudia Adrien
Supplement weight management claims in the GLP-1 era
Asa and other industry leaders weighed in
Earlier this year, California resident Christina Robins sued wellness brand Lemme Inc. accusing it of misleading marketing practices surrounding the company’s GLP-1 Daily supplement.
Aug 7, 2025
Guest Article
Asa Waldstein
Q2 2025 warning letter roundup with Asa Waldstein
In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.
At a Glance
Disease claims made on social media like Facebook and Instagram are fair game for an FDA warning letter.
Ingredients not permitted for use in dietary supplements have a high likelihood of attracting scrutiny.
CBD and delta-8 products are still a concern for FDA and FTC, especially when their packaging may attract children.
May 27, 2025
Interview
Rachel French
Regulators mostly silent on GLP-1 supplement claims
Asa and other industry leaders weigh in
The number of dietary supplement brands that make GLP-1-related claims is spiking. Yet, the emerging category of supplements has been largely met with silence from regulators, creating ambiguity for brands.
Jan 31, 2025
Interview
Cassandra Stern
Olly and BrainPack NAD decisions highlight challenges in supplement advertising
Jennifer Adam and Asa Waldstein provide commentary in this article by Cassandra Stern.
As Olly appeals NAD’s decision and BrainPack modifies its claims, industry experts weigh in on the potential implications for dietary supplement advertising.
Jan 15, 2025
Guest Article
Asa Waldstein
Cognitive and memory warning letters and litigation trends: Best practices for reducing risk
Cognition and memory products are big business, and the Food and Drug Administration (FDA), National Advertising Division (NAD), Federal Trade Commission (FTC) and plaintiff attorneys are paying attention.
Oct 8, 2024
Guest Article
Asa Waldstein
Join me for SupplySide West workshop on nutritional ingredient claims, legal flames
Regulatory consultant Asa Waldstein previews a SupplySide West education session on substantiating claims and clinical trials. Waldstein is moderating the Oct. 28 session that features two attorneys and two experts from contract research organizations.
Apr 18, 2024
Press Mention
Niamh Michail
Revealed: The 18 finalists of the 2024 Vitafoods Europe Startup Innovation Challenge
Find out which trailblazing startups were chosen for their innovative ingredients, finished products, and technologies for the 2024 Vitafoods Europe Startup Innovation Challenge.